Company
CanadaPublic company, NYSE: NVONovo Nordisk A/S (NYSE: NVO), Gentofte, Canada – FDA Inspections
Inspection records and compliance data for Novo Nordisk A/S in Gentofte. Access full analysis and detailed observations. Publicly traded as NYSE: NVO.
Company Profile
This profile covers Novo Nordisk A/S based in Gentofte, Canada.
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Other regulators (1)
- Health Canada · 3 inspections · last March 20, 2025
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Novo Nordisk A/S
Stock ticker
NVO
Exchange
NYSE
Share price
$40.36
Market cap
$178.7B
Price as of
November 6, 2026
Address
Brogardsvej 66, Gentofte, 2820, Canada
Country
Canada
ID: 169bf973-a509-4694-8791-a08dc147c353